Absence of symptomatic benefit of lansoprazole, clarithromycin and amoxicillin (LCA) triple therapy is cure of helicobacter pylori (Hp) positive functional dyspepsia (FD) patients. A randomized double-blind placebo-controlled trial
Sander J. Veldhuyzen van Zanten, Richard Fedorak, Jean Lambert, Lawrence Cohen, Anita VanjakaVolume:
124
Year:
2003
Language:
english
DOI:
10.1016/s0016-5085(03)80911-3
File:
PDF, 174 KB
english, 2003